We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Loss of Gene Found to Accelerate Aging

By Biotechdaily staff writers
Posted on 31 Aug 2005
Scientists have found that the loss of a gene called p63 accelerates aging in mice, according to new research. More...
Similar versions of the gene are present in many organisms, including humans. Therefore, the p63 gene probably plays an essential biologic role in aging-related processes.

"To study how the p63 gene works, we devised a system for eliminating it from adult mouse tissues. What struck us right away was that these p63-deficient mice were aging prematurely,” commented Dr. Alea Mills of Cold Spring Harbor Laboratory (NY, USA), who led the study.

Mice born without the p63 gene do not survive. Therefore, the researchers had earlier performed extensive studies of mice that are born with only one copy of the gene, which demonstrated that these mice die at a young age. Therefore, to assess p63 function in adults, Dr. Mills and coworkers created an advanced molecular genetic method that enabled them to eliminate both copies of the gene from specific tissues--including skin and other multi-layered epithelial tissues--after the mice reached maturity.

The effects of premature aging seen in these p63-deficient mice were reduced fitness and body weight, hair loss, progressive curvature of the spine, and a shortened lifespan. "Aging and cancer are two sides of the same coin. In one case, cells stop dividing and in the other, they can't stop dividing. We suspect that having the right amount of the p63 protein in the right cells at the right time creates a balance that enables organisms to live relatively cancer-free for a reasonably long time,” stated Dr. Mills, who added that this is the first time the p63 gene has been implicated in aging. "I first presented these results at a meeting in Tuscany [Italy]. I don't want to sound flippant, but if you have to grow old somewhere, that's about as good a place as any to do it.”

The study was published in the September 2005 issue of the journal Genes & Development.





Related Links:
Cold Spring Harbor Laboratory

Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
New
Electrolyte Analyzer
BKE-B
New
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image

Urine-Based Multi-Cancer Screening Test Receives FDA Breakthrough Device Designation

Early detection across multiple cancers remains a major unmet need in population screening. Non-invasive approaches that can be delivered at scale may broaden access and shift diagnoses to earlier stages.... Read more

Molecular Diagnostics

view channel
Image: The new approach focuses on CpG DNA methylation, a chemical modification of cytosine and guanine bases, using tumor samples to develop a computational model that distinguishes among 21 cancer types (photo credet: 123RF)

Machine Learning Model Uses DNA Methylation to Predict Tumor Origin in Cancers of Unknown Primary

Cancers of unknown primary (CUP) are metastatic malignancies in which the primary site cannot be identified, complicating treatment selection. Many patients consequently receive broad, nonspecific chemotherapy... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.